Nuveen, LLC Harvard Bioscience Inc Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Nuveen, LLC holds 139,999 shares of HBIO stock, worth $44,799. This represents 0.0% of its overall portfolio holdings.
Number of Shares
139,999Holding current value
$44,799% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HBIO
# of Institutions
95Shares Held
31.5MCall Options Held
0Put Options Held
15K-
Amh Equity LTD3.39MShares$1.08 Million3.14% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$909,9680.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.76MShares$881,7920.35% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.68MShares$858,5600.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.14MShares$684,3990.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $13.3M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...